153 related articles for article (PubMed ID: 26590662)
1. Neuro-oncology dilemma: Tumour or tumefactive demyelinating lesion.
Abdoli M; Freedman MS
Mult Scler Relat Disord; 2015 Nov; 4(6):555-66. PubMed ID: 26590662
[TBL] [Abstract][Full Text] [Related]
2. Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study.
Altintas A; Petek B; Isik N; Terzi M; Bolukbasi F; Tavsanli M; Saip S; Boz C; Aydin T; Arici-Duz O; Ozer F; Siva A
Mult Scler; 2012 Oct; 18(10):1448-53. PubMed ID: 22419670
[TBL] [Abstract][Full Text] [Related]
3. Tumefactive demyelinating lesions of 15 patients: Clinico-radiological features, management and review of the literature.
Sánchez P; Meca-Lallana V; Barbosa A; Manzanares R; Palmí I; Vivancos J
J Neurol Sci; 2017 Oct; 381():32-38. PubMed ID: 28991707
[TBL] [Abstract][Full Text] [Related]
4. Tumour-like lesions in multiple sclerosis.
Jamroz-Wiśniewska A; Janczarek M; Belniak E; Stelmasiak Z; Bartosik-Psujek H
Neurol Neurochir Pol; 2008; 42(2):161-7. PubMed ID: 18512174
[TBL] [Abstract][Full Text] [Related]
5. Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.
Jeong IH; Kim SH; Hyun JW; Joung A; Cho HJ; Kim HJ
J Neurol Sci; 2015 Nov; 358(1-2):118-24. PubMed ID: 26333950
[TBL] [Abstract][Full Text] [Related]
6. Tumefactive demyelination: an approach to diagnosis and management.
Hardy TA; Chataway J
J Neurol Neurosurg Psychiatry; 2013 Sep; 84(9):1047-53. PubMed ID: 23334629
[TBL] [Abstract][Full Text] [Related]
7. Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study.
Siri A; Carra-Dalliere C; Ayrignac X; Pelletier J; Audoin B; Pittion-Vouyovitch S; Debouverie M; Lionnet C; Viala F; Sablot D; Brassat D; Ouallet JC; Ruet A; Brochet B; Taillandier L; Bauchet L; Derache N; Defer G; Cabre P; de Seze J; Lebrun Frenay C; Cohen M; Labauge P
J Neurol; 2015 Jul; 262(7):1637-45. PubMed ID: 25929666
[TBL] [Abstract][Full Text] [Related]
8. Tumefactive demyelinating lesions: A comprehensive review.
Algahtani H; Shirah B; Alassiri A
Mult Scler Relat Disord; 2017 May; 14():72-79. PubMed ID: 28619436
[TBL] [Abstract][Full Text] [Related]
9. Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
Kilic AK; Kurne AT; Oguz KK; Soylemezoglu F; Karabudak R
Turk Neurosurg; 2013; 23(6):728-35. PubMed ID: 24310455
[TBL] [Abstract][Full Text] [Related]
10. Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions.
Tremblay MA; Villanueva-Meyer JE; Cha S; Tihan T; Gelfand JM
J Neurol Sci; 2017 Oct; 381():83-87. PubMed ID: 28991721
[TBL] [Abstract][Full Text] [Related]
11. Tumefactive demyelinating lesion: experience with two unusual patients.
Sinha MK; Garg RK; Bhatt ML; Chandra A
J Postgrad Med; 2010; 56(2):146-9. PubMed ID: 20622396
[TBL] [Abstract][Full Text] [Related]
12. Monophasic, solitary tumefactive demyelinating lesion: neuroimaging features and neuropathological diagnosis.
Tan HM; Chan LL; Chuah KL; Goh NS; Tang KK
Br J Radiol; 2004 Feb; 77(914):153-6. PubMed ID: 15010391
[TBL] [Abstract][Full Text] [Related]
13. Tumefactive Multiple Sclerosis Masquerading as High Grade Glioma.
Lin M; Reid P; Bakhsheshian J
World Neurosurg; 2018 Apr; 112():37-38. PubMed ID: 29331745
[TBL] [Abstract][Full Text] [Related]
14. Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.
Totaro R; Di Carmine C; Splendiani A; Torlone S; Patriarca L; Carrocci C; Sciamanna S; Marini C; Carolei A
Neurol Sci; 2016 Jul; 37(7):1113-7. PubMed ID: 27083895
[TBL] [Abstract][Full Text] [Related]
15. [A case of pediatric multiple sclerosis presenting with a tumefactive demyelinating lesion].
Majima H; Ito T; Koyama N
Rinsho Shinkeigaku; 2017 Feb; 57(2):88-91. PubMed ID: 28132974
[TBL] [Abstract][Full Text] [Related]
16. Solitary tumefactive demyelinating lesions in children.
Morin MP; Patenaude Y; Sinsky AB; Banwell B; Sébire G
J Child Neurol; 2011 Aug; 26(8):995-9. PubMed ID: 21555780
[TBL] [Abstract][Full Text] [Related]
17. Histogram analysis of apparent diffusion coefficient maps for differentiating primary CNS lymphomas from tumefactive demyelinating lesions.
Lu SS; Kim SJ; Kim N; Kim HS; Choi CG; Lim YM
AJR Am J Roentgenol; 2015 Apr; 204(4):827-34. PubMed ID: 25794073
[TBL] [Abstract][Full Text] [Related]
18. Pediatric tumefactive demyelination: case series and review of the literature.
McAdam LC; Blaser SI; Banwell BL
Pediatr Neurol; 2002 Jan; 26(1):18-25. PubMed ID: 11814730
[TBL] [Abstract][Full Text] [Related]
19. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
Saini J; Chatterjee S; Thomas B; Kesavadas C
Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
[TBL] [Abstract][Full Text] [Related]
20. Tumefactive demyelinating lesions: nine cases and a review of the literature.
Xia L; Lin S; Wang ZC; Li SW; Xu L; Wu J; Hao SY; Gao CC
Neurosurg Rev; 2009 Apr; 32(2):171-9; discussion 179. PubMed ID: 19172322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
